Grant: Catalyst: Methods Post-Market DSE - Bayesian methods and statistical models
University of Calgary
$99,744.00
Bayesian models for synthesizing randomized controlled trials and patients' preferences for treatment options in early rheumatoid arthritis and Crohn's disease
EF 2014-15
Résumé
Rheumatoid arthritis and Crohn's disease are chronic conditions that affect all ages. Both conditions are caused by the body's immune system attacking healthy cells in different parts of the body. In rheumatoid arthritis, the immune system attacks the joints, resulting in joint swelling, pain, and difficulty moving. In Crohn's disease, the gastrointestinal tract or intestines are affected, resulting in pain, diarrhea and weight loss. Both conditions have a large impact on patients' quality of life. There is no cure for either disease, but fortunately many treatment options are available for both. All of the treatments work on the immune system to prevent the body from attacking its own cells. Choosing the right treatment can be difficult. Some treatments may work better but have potential side effects. Some medications are taken as pills and others as injections at home or infusions through a vein in a clinic. Choosing the right treatment for the right patient requires an understanding of what is important to people living with these conditions. In this project we will bring research evidence and patients' preferences together to help determine which treatments best match patients' preferences. This will involve 2 parts. First, we will conduct a survey in patients with Crohn's disease (we have already done this for patients with rheumatoid arthritis) where we determine patients' preferences. Second, we will combine this information with the best available research evidence in a mathematical model to determine which treatment patients would prefer. We will do this separately for rheumatoid arthritis and Crohn's disease. Currently, treatment recommendations for both conditions are made primarily based on research evidence alone. This grant will develop a novel method to help inform patient-centered treatment approaches to improve the lives of patients with both Crohn's disease and rheumatoid arthritis.
Programme
Catalyst: Methods Post-Market DSE - Bayesian methods and statistical models
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
327715
Name
Hazlewood Glen S
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Drug Safety and Effectiveness Research Methods
Projecttitle
Bayesian models for synthesizing randomized controlled trials and patients' preferences for treatment options in early rheumatoid arthritis and Crohn's disease
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$99,744
Cihrequipment2
$0
Programname2
Catalyst: Methods Post-Market DSE - Bayesian methods and statistical models
Keyworddelim
Bayesian Methods; Crohn'S Disease; Discrete-Choice Experiment; Drug Evaluation; Network Meta-Analysis; Patient Preferences; Rheumatoid Arthritis; Treatment Recommendations
Abstract
Rheumatoid arthritis and Crohn's disease are chronic conditions that affect all ages. Both conditions are caused by the body's immune system attacking healthy cells in different parts of the body. In rheumatoid arthritis, the immune system attacks the joints, resulting in joint swelling, pain, and difficulty moving. In Crohn's disease, the gastrointestinal tract or intestines are affected, resulting in pain, diarrhea and weight loss. Both conditions have a large impact on patients' quality of life. There is no cure for either disease, but fortunately many treatment options are available for both. All of the treatments work on the immune system to prevent the body from attacking its own cells. Choosing the right treatment can be difficult. Some treatments may work better but have potential side effects. Some medications are taken as pills and others as injections at home or infusions through a vein in a clinic. Choosing the right treatment for the right patient requires an understanding of what is important to people living with these conditions. In this project we will bring research evidence and patients' preferences together to help determine which treatments best match patients' preferences. This will involve 2 parts. First, we will conduct a survey in patients with Crohn's disease (we have already done this for patients with rheumatoid arthritis) where we determine patients' preferences. Second, we will combine this information with the best available research evidence in a mathematical model to determine which treatment patients would prefer. We will do this separately for rheumatoid arthritis and Crohn's disease. Currently, treatment recommendations for both conditions are made primarily based on research evidence alone. This grant will develop a novel method to help inform patient-centered treatment approaches to improve the lives of patients with both Crohn's disease and rheumatoid arthritis.
Competitiondate
201501
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hazlewood, Glen S; Kaplan, Gilaad G
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $99,744~ $0~